HTGF invests in PS Biotech

The German VC previously backed PS Biotech in June this year in a seed financing round.

The firm is expected to launch its product on the market in Autumn this year.

HTGF currently holds 39 biotech start-ups in its portfolio.

Company
PS Biotech is a spin-off from RWTH Aachen and the DWI at RWTH Aachen. It was founded in May 2013.

The firm produces special microtiter plates, which enable a more realistic screening of micro-organisms. The firm produces a polymer-based release system, allowing a fed-batch feeding of micro-organisms.

People
Kristina Bruellhoff is managing director and co-founder of PS Biotech. Christian Jung is investment manager at HTGF.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Early-stage
• Technology
• Germany
• High-Tech Gründerfonds